UBS Group
DBD icon

UBS Group’s Diebold Nixdorf DBD Stock Holding History

UBS Group’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
196,071
+105,442
+116% +$8.48M ﹤0.01% 2885
2026
Q1 		$6.84M Sell
90,629
-6,376
-7% -$469K ﹤0.01% 3746
2025
Q4 		$6.59M Sell
97,005
-41,537
-30% -$2.59M ﹤0.01% 3740
2025
Q3 		$7.9M Buy
138,542
+25,573
+23% +$1.52M ﹤0.01% 3545
2025
Q2 		$6.26M Buy
112,969
+1,957
+2% +$91.8K ﹤0.01% 3636
2025
Q1 		$4.85M Buy
111,012
+819
+0.7% +$35.7K ﹤0.01% 3812
2024
Q4 		$4.74M Buy
110,193
+96,134
+684% +$4.33M ﹤0.01% 3909
2024
Q3 		$628K Buy
14,059
+4,563
+48% +$189K ﹤0.01% 5048
2024
Q2 		$365K Buy
9,496
+8,016
+542% +$305K ﹤0.01% 5235
2024
Q1 		$51K Buy
+1,480
New +$47.5K ﹤0.01% 6497
2023
Q4 		– Sell
-38,355
Closed -$726K – 9395
2023
Q3 		$726K Buy
+38,355
New +$728K ﹤0.01% 4366

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's DBD Position: Q2 2026 in Review

UBS Group increased its Diebold Nixdorf (DBD) stake by 116% in Q2 2026, buying an estimated $8.48M and bringing the position to 196,071 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2885.

UBS Group first reported a position in DBD in Q3 2023 and has held it in 11 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • UBS Group held 196,071 shares of Diebold Nixdorf worth $16.7M as of Q2 2026.
  • UBS Group bought 105,442 Diebold Nixdorf shares in Q2 2026, an estimated $8.48M.
  • Diebold Nixdorf made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2885 holding.
  • UBS Group first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 11 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.